Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Armitage

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
European Radiology Experimental|July 9, 2024
High-resolution and highly accelerated MRI T2 mapping as a tool to characterise renal tumour subtypes and gradesInes Horvat-Menih, Hao Li, Andrew N Priest, et al.
BJU International|September 22, 2021
Dynamic biomarker and imaging changes from a phase II study of pre- and post-surgical sunitinibSarah J Welsh, Nicola Thompson, Anne Warren, et al.
NMR in Biomedicine|June 24, 2026
Estimating the Sodium Content: A Case Series of Benign and Malignant Renal Tumours Using <sup>23</sup>Na-MRI at 3 TInes Horvat-Menih, Jonathan R Birchall, Maria J Zamora-Morales, et al.
BMJ Open|October 26, 2024
Multiarm, non-randomised, single-centre feasibility study-investigation of the differential biology between benign and malignant renal masses using advanced magnetic resonance imaging techniques (IBM-Renal): protocolInes Horvat-Menih, Mary A McLean, Maria Jesus Zamora-Morales, et al.
European Urology Oncology|October 15, 2025
Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC): A Nonrandomised Feasibility StudyChiara Re, James P Blackmur, Teele Kuusk, et al.
Journal of Cancer Research and Clinical Oncology|April 3, 2026
Improving the diagnosis of renal tumours of young people through integrated molecular analysisSarah M Leiter, Aisosa O Guobadia, Ben Fleming, et al.
Genome Medicine|March 1, 2020
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumorsChristopher G Smith, Tina Moser, Florent Mouliere, et al.
Cancer Cell|November 24, 2022
Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancerRuoyan Li, John R Ferdinand, Kevin W Loudon, et al.
Abdominal Radiology (New York)|December 10, 2025
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-<sup>13</sup> C]pyruvate MRIInes Horvat-Menih, Mary A McLean, Jonathan Birchall, et al.
Cancers|January 21, 2022
Hyperpolarized <sup>13</sup>C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma-A Proof of Principle StudyStephan Ursprung, Ramona Woitek, Mary A McLean, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
European Radiology Experimental|July 9, 2024
High-resolution and highly accelerated MRI T2 mapping as a tool to characterise renal tumour subtypes and gradesInes Horvat-Menih, Hao Li, Andrew N Priest, et al.
BJU International|September 22, 2021
Dynamic biomarker and imaging changes from a phase II study of pre- and post-surgical sunitinibSarah J Welsh, Nicola Thompson, Anne Warren, et al.
NMR in Biomedicine|June 24, 2026
Estimating the Sodium Content: A Case Series of Benign and Malignant Renal Tumours Using <sup>23</sup>Na-MRI at 3 TInes Horvat-Menih, Jonathan R Birchall, Maria J Zamora-Morales, et al.
BMJ Open|October 26, 2024
Multiarm, non-randomised, single-centre feasibility study-investigation of the differential biology between benign and malignant renal masses using advanced magnetic resonance imaging techniques (IBM-Renal): protocolInes Horvat-Menih, Mary A McLean, Maria Jesus Zamora-Morales, et al.
European Urology Oncology|October 15, 2025
Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC): A Nonrandomised Feasibility StudyChiara Re, James P Blackmur, Teele Kuusk, et al.
Journal of Cancer Research and Clinical Oncology|April 3, 2026
Improving the diagnosis of renal tumours of young people through integrated molecular analysisSarah M Leiter, Aisosa O Guobadia, Ben Fleming, et al.
Genome Medicine|March 1, 2020
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumorsChristopher G Smith, Tina Moser, Florent Mouliere, et al.
Cancer Cell|November 24, 2022
Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancerRuoyan Li, John R Ferdinand, Kevin W Loudon, et al.
Abdominal Radiology (New York)|December 10, 2025
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-<sup>13</sup> C]pyruvate MRIInes Horvat-Menih, Mary A McLean, Jonathan Birchall, et al.
Cancers|January 21, 2022
Hyperpolarized <sup>13</sup>C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma-A Proof of Principle StudyStephan Ursprung, Ramona Woitek, Mary A McLean, et al.
Pageof 7